Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Most adverse drug reactions unreported, study finds
The researchers also want regulators to make reporting quicker and easier.
Researchers urge vets to report suspected cases.

Veterinary professionals are being encouraged to report suspected adverse drug reactions, after a new study found that the vast majority were not reported.

Researchers from the University of Liverpool reviewed more than 10,000 electronic health records from the Small Animal Veterinary Surveillance Network (SAVSNET). They found 827 cases of suspected adverse drug reactions, of which around 90 per cent went unreported.

Heather Davies, lead author of the study, explained: “It has long been thought that adverse drug reactions are under-reported. This work used real world evidence from first opinion practice to be the first publication that confirms this suspicion.”

Free-text clinical narratives of consultations stored in SAVSNET were screened for the phrases ‘adverse drug reaction’ and ‘side effect’.

The researchers then analysed the records to determine the seriousness and expectedness of the reaction, the suspected product, and whether it had been reported to the Veterinary Medicines Directorate (VMD) or the relevant marketing authorisation holder.

Most of the cases involved dogs and 70 per cent were listed as ‘expected’. Reactions which were not expected were more likely to be reported. The study also found that there was no correlation between the clinical severity of the reaction and how likely to was to be reported.

Dr Davies added: “As adverse drug reaction reporting rate is directly linked to the regulator's ability to mitigate safety issues, this paper is a call to arms encouraging all veterinary professionals to report suspected adverse drug reactions and regulators to make reporting quicker and easier.

“It also the highlights the promise that big real-world data sets hold in enhancing drug safety monitoring processes.”

The study, which received funding from BSAVA PetSavers and the VMD, has been published in the Journal of Small Animal Practice.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Strangles survey seeks views of horse owners

News Story 1
 With Strangles Awareness Week just around the corner (5-11 May), vets are being encouraged to share a survey about the disease with their horse-owning clients.

The survey, which has been designed by Dechra, aims to raise awareness of Strangles and promote best practices to prevent its transmission. It includes questions about horse owners' experiences of strangles, together with preventative measures and vaccination.

Respondents to the survey will be entered into a prize draw to win two VIP tickets to Your Horse Live 2025. To access the survey, click here 

Click here for more...
News Shorts
DAERA to reduce BVD 'grace period'

DAERA has reminded herd keepers of an upcoming reduction to the 'grace period' to avoid BVD herd restrictions.

From 1 May 2025, herd keepers will have seven days to cull any BVD positive or inconclusive animals to avoid restrictions being applied to their herd.

It follows legislation introduced on 1 February, as DAERA introduces herd movement restrictions through a phased approach. Herd keepers originally had 28 days to cull BVD positive or inconclusive animals.

DAERA says that, providing herd keepers use the seven-day grace period, no herds should be restricted within the first year of these measures.

Additional measures, which will target herds with animals over 30 days old that haven't been tested for BVD, will be introduced from 1 June 2025.

More information is available on the DAERA website.